Search

everythinglearnresearchcommunity

for

Search:↓

Personalized thiopurine dosing based on NUDT15 genotyping can improve long-term outcomes for ulcerative colitis and Crohn's disease patients.

Dutasteride may help reduce brain plaque linked to Alzheimer's by affecting cell energy structures and waste removal.

The hair treatment materials are safe to use.

Rituximab leads to longer remission and fewer side effects than cyclophosphamide.

Far-infrared radiation improves stem cell growth and movement, helping heart therapy.

New markers can detect tumors, aid drug delivery, and treat cancer effectively and safely.

Ruby laser hair removal does not cause increased cell growth in the skin.

New treatments and diagnostic methods for urological conditions show promise, but some lack sufficient accuracy for clinical use.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Tolterodine Tartrate effectively treats overactive bladder symptoms.

Combined BRAF and MEK treatment increases rash risk but reduces other skin issues compared to BRAF alone.

Estradiol and castration reduced prostate cancer development in rats when applied at early stages, but were ineffective after cancer was established.

Procyanidin B-2 lotion might help men grow thicker hair without side effects.

Arsenic trioxide effectively treats APL, improving survival rates despite its toxicity.

High-intensity red LED light boosts bone cell growth and mineralization.

Vismodegib effectively treats advanced basal cell carcinoma but requires careful management of serious side effects.

A new method improves betulin delivery in experiments, showing promise against certain tumors.

Alkylating agents can kill cancer cells but may cause skin and allergic reactions.

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

Inhibiting 5α-reductase increases progesterone levels in late pregnant mares.

The treatment was not recommended due to limited effectiveness and significant side effects.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

Deucravacitinib led to full hair regrowth in a severe alopecia areata patient.

Extending androgen suppression before radiotherapy offers no extra survival benefit for intermediate-risk prostate cancer.

Deferasirox combined with sorafenib reduces liver cancer risk and lessens treatment side effects.

BMS-470539 reduces skin fibrosis and inflammation.

Nanoparticle delivery can reduce side effects of the cancer drug doxorubicin.